المؤلفون: Ciurea, SO, Zhang, MJ, Bacigalupo, AA, Bashey, A, Appelbaum, FR, Aljitawi, OS, Armand, P, Antin, JH, Chen, JF, Devine, SM, Fowler, DH, Luznik, L, Nakamura, R, O'Donnell, PV, Perales, MA, Pingali, SR, Porter, DL, Riches, MR, Ringden, OTH, Rocha, V, Vij, R, Weisdorf, DJ, Champlin, RE, Horowitz, MM, Fuchs, EJ, Eapen, M

المصدر: Blood. 126(8):1033-1040

مصطلحات موضوعية: Medicin och hälsovetenskap

URL الوصول: http://kipublications.ki.se/Default.aspx?queryparsed=id:131909493

المؤلفون: Pingali Srilakshmi

المصدر: Telangana Journal of Psychiatry, Vol 6, Iss 1, Pp 7-8 (2020)

مصطلحات موضوعية: Psychiatry, RC435-571

وصف الملف: electronic resource

Relation: http://www.tjpipstsb.org/article.asp?issn=2455-8559;year=2020;volume=6;issue=1;spage=7;epage=8;aulast=Srilakshmi;type=0; https://doaj.org/toc/2455-8559

URL الوصول: https://doaj.org/article/fb836837078f4815bf4980f295b067cc

المؤلفون: Mai S; Center for Immunotherapy, Neal Cancer Center, Houston Methodist Research Institute, Houston, Texas., Hodges A; Center for Immunotherapy, Neal Cancer Center, Houston Methodist Research Institute, Houston, Texas.; Texas A&M University System School of Medicine, Bryan, Texas., Chen HM; Center for Immunotherapy, Neal Cancer Center, Houston Methodist Research Institute, Houston, Texas., Zhang J; Center for Immunotherapy, Neal Cancer Center, Houston Methodist Research Institute, Houston, Texas., Wang YL; Center for Immunotherapy, Neal Cancer Center, Houston Methodist Research Institute, Houston, Texas., Liu Y; Center for Immunotherapy, Neal Cancer Center, Houston Methodist Research Institute, Houston, Texas., Nakatsu F; Department of Oncological Sciences, Icahn School of Medicine at Mount Sinai, New York, New York., Wang X; Center for Immunotherapy, Neal Cancer Center, Houston Methodist Research Institute, Houston, Texas., Fang J; Center for Immunotherapy, Neal Cancer Center, Houston Methodist Research Institute, Houston, Texas., Xu Y; Center for Immunotherapy, Neal Cancer Center, Houston Methodist Research Institute, Houston, Texas., Davidov V; Center for Immunotherapy, Neal Cancer Center, Houston Methodist Research Institute, Houston, Texas.; Texas A&M University System School of Medicine, Bryan, Texas., Kang K; Center for Immunotherapy, Neal Cancer Center, Houston Methodist Research Institute, Houston, Texas., Pingali SR; Center for Immunotherapy, Neal Cancer Center, Houston Methodist Research Institute, Houston, Texas.; Division of Hematology, Medical Oncology and Hematology, Houston Methodist Hospital, Houston, Texas., Ganguly S; Center for Immunotherapy, Neal Cancer Center, Houston Methodist Research Institute, Houston, Texas.; Division of Hematology, Medical Oncology and Hematology, Houston Methodist Hospital, Houston, Texas., Suzuki M; Center for Gene Therapy, Baylor College of Medicine, Houston, Texas., Konopleva M; Department of Oncology, Albert Einstein College of Medicine, Bronx, New York., Prinzing B; Department of Bone Marrow Transplantation & Cellular Therapy, St Jude Children's Research Hospital, Memphis, Tennessee., Zu Y; Department of Pathology & Genomic Medicine, Houston Methodist Research Institute, Houston Texas., Gottschalk S; Department of Bone Marrow Transplantation & Cellular Therapy, St Jude Children's Research Hospital, Memphis, Tennessee., Lu Y; Center for Immunotherapy, Neal Cancer Center, Houston Methodist Research Institute, Houston, Texas., Chen SH; Center for Immunotherapy, Neal Cancer Center, Houston Methodist Research Institute, Houston, Texas.; Texas A&M University System School of Medicine, Bryan, Texas.; Department of Physiology, Biophysics, and Systems Biology, Weill Cornell Medical Science and Graduate School of Medical Sciences, New York, New York., Pan PY; Center for Immunotherapy, Neal Cancer Center, Houston Methodist Research Institute, Houston, Texas.; Texas A&M University System School of Medicine, Bryan, Texas.

المصدر: Cancer research [Cancer Res] 2023 Dec 15; Vol. 83 (24), pp. 4047-4062.

نوع المنشور: Journal Article; Research Support, Non-U.S. Gov't

بيانات الدورية: Publisher: American Association for Cancer Research Country of Publication: United States NLM ID: 2984705R Publication Model: Print Cited Medium: Internet ISSN: 1538-7445 (Electronic) Linking ISSN: 00085472 NLM ISO Abbreviation: Cancer Res Subsets: MEDLINE

مواضيع طبية MeSH: Immunotherapy, Adoptive*/methods , Leukemia, Myeloid, Acute*/pathology, Humans ; T-Lymphocytes ; Receptors, Cell Surface/metabolism ; Myeloid Cells/metabolism ; Receptors, Immunologic/metabolism ; Antigens, CD/metabolism

المؤلفون: Burns EA; Neal Cancer Center, Houston Methodist Hospital, 6445 Main Street, Outpatient Center, 24th Floor., Houston, TX, 77030, USA., Wilson JJ; Trinity School of Medicine, 925 Woodstock Road, Ste 200, GA, Roswell, USA., Mathur S; Neal Cancer Center, Houston Methodist Hospital, 6445 Main Street, Outpatient Center, 24th Floor., Houston, TX, 77030, USA., Kieser R; Neal Cancer Center, Houston Methodist Hospital, 6445 Main Street, Outpatient Center, 24th Floor., Houston, TX, 77030, USA., Gong Z; Neal Cancer Center, Houston Methodist Hospital, 6445 Main Street, Outpatient Center, 24th Floor., Houston, TX, 77030, USA., Hu CA; Center for Translational Research in Hematologic Malignancies, Neal Cancer Center, Houston Methodist Research Institute, 6550 Fannin St, Houston, TX, 77030, USA., Tang CA; Center for Translational Research in Hematologic Malignancies, Neal Cancer Center, Houston Methodist Research Institute, 6550 Fannin St, Houston, TX, 77030, USA., Petkova J; Department of Academic Medicine, Houston Methodist Hospital, 6550 Fannin St Ste. 1001, Houston, TX, 77030, USA., Yuen C; Neal Cancer Center, Houston Methodist Hospital, 6445 Main Street, Outpatient Center, 24th Floor., Houston, TX, 77030, USA., Mai H; Neal Cancer Center, Houston Methodist Hospital, 6445 Main Street, Outpatient Center, 24th Floor., Houston, TX, 77030, USA., Shah S; Neal Cancer Center, Houston Methodist Hospital, 6445 Main Street, Outpatient Center, 24th Floor., Houston, TX, 77030, USA., Rice L; Neal Cancer Center, Houston Methodist Hospital, 6445 Main Street, Outpatient Center, 24th Floor., Houston, TX, 77030, USA.; Department of Academic Medicine, Houston Methodist Hospital, 6550 Fannin St Ste. 1001, Houston, TX, 77030, USA., Ganguly S; Neal Cancer Center, Houston Methodist Hospital, 6445 Main Street, Outpatient Center, 24th Floor., Houston, TX, 77030, USA., Pingali SR; Neal Cancer Center, Houston Methodist Hospital, 6445 Main Street, Outpatient Center, 24th Floor., Houston, TX, 77030, USA. SPingali@houstonmethodist.org.

المصدر: Annals of hematology [Ann Hematol] 2023 Oct; Vol. 102 (10), pp. 2753-2763. Date of Electronic Publication: 2023 Jul 08.

نوع المنشور: Journal Article

بيانات الدورية: Publisher: Springer Verlag Country of Publication: Germany NLM ID: 9107334 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1432-0584 (Electronic) Linking ISSN: 09395555 NLM ISO Abbreviation: Ann Hematol Subsets: MEDLINE

مواضيع طبية MeSH: Burkitt Lymphoma*/drug therapy , Burkitt Lymphoma*/epidemiology, Humans ; Aged ; Texas/epidemiology ; Registries

المؤلفون: Chevli N; Department of Radiation Oncology, University of Texas Medical Branch, Galveston, Texas., Margolis V; Department of Radiation Oncology, University of Texas Medical Branch, Galveston, Texas., Haque W; Department of Radiation Oncology, Houston Methodist Hospital, Houston, Texas; and., Pingali SR; Department of Medical Oncology, Houston Methodist Hospital, Houston, Texas., Butler EB; Department of Radiation Oncology, Houston Methodist Hospital, Houston, Texas; and., Teh BS; Department of Radiation Oncology, Houston Methodist Hospital, Houston, Texas; and. Electronic address: bteh@houstonmethodist.org.

المصدر: Practical radiation oncology [Pract Radiat Oncol] 2023 Jan-Feb; Vol. 13 (1), pp. e80-e93. Date of Electronic Publication: 2022 Oct 09.

نوع المنشور: Journal Article

بيانات الدورية: Publisher: Elsevier Country of Publication: United States NLM ID: 101558279 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1879-8519 (Electronic) Linking ISSN: 18798500 NLM ISO Abbreviation: Pract Radiat Oncol Subsets: MEDLINE

مواضيع طبية MeSH: Lymphoma*, Humans ; Aged ; Prognosis ; Kaplan-Meier Estimate

المؤلفون: Lee AC; Center for Translational Research in Hematologic Malignancies, Houston Methodist Cancer Center, Houston Methodist Research Institute, Houston, TX, USA.; Cell & Molecular Biology Graduate Group, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA, USA., Pingali SR; Center for Translational Research in Hematologic Malignancies, Houston Methodist Cancer Center, Houston Methodist Research Institute, Houston, TX, USA., Pinilla-Ibarz JA; Department of Malignant Hematology, H. Lee Moffitt Cancer Center & Research Institute, Tampa, FL, USA., Atchison ML; Department of Biomedical Sciences, School of Veterinary Medicine, University of Pennsylvania, Philadelphia, PA, USA., Koumenis C; Department of Radiation Oncology, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA, USA., Argon Y; Department of Pathology and Laboratory Medicine, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA, USA.; Division of Cell Pathology, Children's Hospital of Philadelphia, Philadelphia, PA, USA., Thomas-Tikhonenko A; Department of Pathology and Laboratory Medicine, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA, USA.; Division of Cancer Pathobiology, Children's Hospital of Philadelphia, Philadelphia, PA, USA., De Trez C; Laboratory of Cellular and Molecular Immunology, Vrije Universiteit Brussel, Brussels, Belgium., Hu CA; Center for Translational Research in Hematologic Malignancies, Houston Methodist Cancer Center, Houston Methodist Research Institute, Houston, TX, USA. cahu@houstonmethodist.org., Tang CA; Center for Translational Research in Hematologic Malignancies, Houston Methodist Cancer Center, Houston Methodist Research Institute, Houston, TX, USA. catang@houstonmethodist.org.

المصدر: Leukemia [Leukemia] 2022 Oct; Vol. 36 (10), pp. 2430-2442. Date of Electronic Publication: 2022 Aug 30.

نوع المنشور: Journal Article; Research Support, N.I.H., Extramural

بيانات الدورية: Publisher: Nature Publishing Group, Specialist Journals Country of Publication: England NLM ID: 8704895 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1476-5551 (Electronic) Linking ISSN: 08876924 NLM ISO Abbreviation: Leukemia Subsets: MEDLINE

مواضيع طبية MeSH: Leukemia, Lymphocytic, Chronic, B-Cell*/pathology, Animals ; Cytidine Deaminase/genetics ; Mice ; Mice, Knockout ; Protein Serine-Threonine Kinases ; RNA, Messenger/genetics ; Receptors, Antigen, B-Cell/genetics

المؤلفون: Gentille C; Houston Methodist Cancer Center, Houston, Texas, USA., Sarfraz H; Houston Methodist Hospital, Houston, Texas, USA., Joshi J; Houston Methodist Cancer Center, Houston, Texas, USA., Randhawa J; Houston Methodist Cancer Center, Houston, Texas, USA., Shah S; Houston Methodist Cancer Center, Houston, Texas, USA., Pingali SR; Houston Methodist Cancer Center, Houston, Texas, USA.

المصدر: Cancer reports (Hoboken, N.J.) [Cancer Rep (Hoboken)] 2022 Jul; Vol. 5 (7), pp. e1581. Date of Electronic Publication: 2022 Mar 08.

نوع المنشور: Journal Article

بيانات الدورية: Publisher: John Wiley & Sons, Inc Country of Publication: United States NLM ID: 101747728 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 2573-8348 (Electronic) Linking ISSN: 25738348 NLM ISO Abbreviation: Cancer Rep (Hoboken) Subsets: MEDLINE

مواضيع طبية MeSH: Lymphoma, T-Cell, Peripheral*/drug therapy, Antineoplastic Combined Chemotherapy Protocols/therapeutic use ; Brentuximab Vedotin/therapeutic use ; Carboplatin/therapeutic use ; Depsipeptides/therapeutic use ; Etoposide/therapeutic use ; Humans ; Ifosfamide/therapeutic use ; Ki-1 Antigen ; Neoplasm Recurrence, Local/drug therapy ; Retrospective Studies

المؤلفون: Su P; Center for Translational Research in Hematological Malignancies, Houston Methodist Cancer Center/Houston Methodist Research Institute, Houston, TX, USA., Xiao L; Center for Translational Research in Hematological Malignancies, Houston Methodist Cancer Center/Houston Methodist Research Institute, Houston, TX, USA., Ye L; Center for Translational Research in Hematological Malignancies, Houston Methodist Cancer Center/Houston Methodist Research Institute, Houston, TX, USA., Wang Z; Center for Translational Research in Hematological Malignancies, Houston Methodist Cancer Center/Houston Methodist Research Institute, Houston, TX, USA., Xiong W; Center for Translational Research in Hematological Malignancies, Houston Methodist Cancer Center/Houston Methodist Research Institute, Houston, TX, USA., Wang Q; Center for Translational Research in Hematological Malignancies, Houston Methodist Cancer Center/Houston Methodist Research Institute, Houston, TX, USA., Ma X; Center for Translational Research in Hematological Malignancies, Houston Methodist Cancer Center/Houston Methodist Research Institute, Houston, TX, USA., Xian M; Center for Translational Research in Hematological Malignancies, Houston Methodist Cancer Center/Houston Methodist Research Institute, Houston, TX, USA., Yang M; Center for Translational Research in Hematological Malignancies, Houston Methodist Cancer Center/Houston Methodist Research Institute, Houston, TX, USA., Zu Y; Department of Pathology and Genomic Medicine, Institute for Academic Medicine, Houston Methodist Research Institute, Houston, TX, USA., Pingali SR; Houston Methodist Cancer Center, Houston Methodist Hospital, Houston, TX, USA., Qian J; Center for Translational Research in Hematological Malignancies, Houston Methodist Cancer Center/Houston Methodist Research Institute, Houston, TX, USA., Yi Q; Center for Translational Research in Hematological Malignancies, Houston Methodist Cancer Center/Houston Methodist Research Institute, Houston, TX, USA. QYi@houstonmethodist.org.

المصدر: Journal of hematology & oncology [J Hematol Oncol] 2022 May 07; Vol. 15 (1), pp. 55. Date of Electronic Publication: 2022 May 07.

نوع المنشور: Letter; Research Support, N.I.H., Extramural

بيانات الدورية: Publisher: Biomed Central Country of Publication: England NLM ID: 101468937 Publication Model: Electronic Cited Medium: Internet ISSN: 1756-8722 (Electronic) Linking ISSN: 17568722 NLM ISO Abbreviation: J Hematol Oncol Subsets: MEDLINE

مواضيع طبية MeSH: Multiple Myeloma*/drug therapy , Multiple Myeloma*/metabolism , Proteasome Inhibitors*, Apoptosis ; Humans ; Lysophospholipids/metabolism ; Lysophospholipids/pharmacology

المؤلفون: Friend BD; Center for Cell and Gene Therapy, Baylor College of Medicine, Texas Children's Hospital, Houston, TX, USA. bdfriend@texaschildrens.org., Muhsen IN; Department of Medicine, Houston Methodist Hospital, Houston, TX, USA., Patel S; Department of Pediatrics, McGovern Medical School, University of Texas Health Science Center at Houston, Houston, TX, USA., Hill LC; Center for Cell and Gene Therapy, Baylor College of Medicine, Houston Methodist Hospital, Houston, TX, USA., Lulla P; Center for Cell and Gene Therapy, Baylor College of Medicine, Houston Methodist Hospital, Houston, TX, USA., Ramos CA; Center for Cell and Gene Therapy, Baylor College of Medicine, Houston Methodist Hospital, Houston, TX, USA., Pingali SR; Houston Methodist Cancer Center, Houston, TX, USA., Kamble RT; Center for Cell and Gene Therapy, Baylor College of Medicine, Houston Methodist Hospital, Houston, TX, USA., John TD; Center for Cell and Gene Therapy, Baylor College of Medicine, Texas Children's Hospital, Houston, TX, USA., Salem B; Center for Cell and Gene Therapy, Baylor College of Medicine, Texas Children's Hospital, Houston, TX, USA., Bhar S; Center for Cell and Gene Therapy, Baylor College of Medicine, Texas Children's Hospital, Houston, TX, USA., Doherty EE; Center for Cell and Gene Therapy, Baylor College of Medicine, Texas Children's Hospital, Houston, TX, USA., Craddock J; Center for Cell and Gene Therapy, Baylor College of Medicine, Texas Children's Hospital, Houston, TX, USA., Sasa G; Center for Cell and Gene Therapy, Baylor College of Medicine, Texas Children's Hospital, Houston, TX, USA., Wu M; Center for Cell and Gene Therapy, Baylor College of Medicine, Texas Children's Hospital, Houston, TX, USA.; Center for Cell and Gene Therapy, Baylor College of Medicine, Houston Methodist Hospital, Houston, TX, USA., Wang T; Center for Cell and Gene Therapy, Baylor College of Medicine, Texas Children's Hospital, Houston, TX, USA.; Center for Cell and Gene Therapy, Baylor College of Medicine, Houston Methodist Hospital, Houston, TX, USA., Martinez C; Center for Cell and Gene Therapy, Baylor College of Medicine, Texas Children's Hospital, Houston, TX, USA., Krance RA; Center for Cell and Gene Therapy, Baylor College of Medicine, Texas Children's Hospital, Houston, TX, USA., Heslop HE; Center for Cell and Gene Therapy, Baylor College of Medicine, Texas Children's Hospital, Houston, TX, USA.; Center for Cell and Gene Therapy, Baylor College of Medicine, Houston Methodist Hospital, Houston, TX, USA., Carrum G; Center for Cell and Gene Therapy, Baylor College of Medicine, Houston Methodist Hospital, Houston, TX, USA.

المصدر: Bone marrow transplantation [Bone Marrow Transplant] 2022 Apr; Vol. 57 (4), pp. 579-585. Date of Electronic Publication: 2022 Feb 01.

نوع المنشور: Journal Article

بيانات الدورية: Publisher: Nature Publishing Group Country of Publication: England NLM ID: 8702459 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1476-5365 (Electronic) Linking ISSN: 02683369 NLM ISO Abbreviation: Bone Marrow Transplant Subsets: MEDLINE

مواضيع طبية MeSH: Hematopoietic Stem Cell Transplantation* , Hodgkin Disease*/drug therapy , Hodgkin Disease*/pathology, Adolescent ; Adult ; Aged ; Antineoplastic Combined Chemotherapy Protocols ; Carmustine/therapeutic use ; Child ; Cytarabine ; Humans ; Melphalan ; Middle Aged ; Neoplasm Recurrence, Local/drug therapy ; Retrospective Studies ; Rituximab/therapeutic use ; Transplantation Conditioning ; Transplantation, Autologous ; Young Adult

المؤلفون: Wang Q; Center for Translational Research in Hematological Malignancies, Houston Methodist Cancer Center/Houston Methodist Research Institute, Houston, Texas., Lin Z; Center for Translational Research in Hematological Malignancies, Houston Methodist Cancer Center/Houston Methodist Research Institute, Houston, Texas.; Department of Hematology, The First Affiliated Hospital of Xiamen University, Xiamen, Fujian, China., Wang Z; Center for Translational Research in Hematological Malignancies, Houston Methodist Cancer Center/Houston Methodist Research Institute, Houston, Texas., Ye L; Center for Translational Research in Hematological Malignancies, Houston Methodist Cancer Center/Houston Methodist Research Institute, Houston, Texas., Xian M; Center for Translational Research in Hematological Malignancies, Houston Methodist Cancer Center/Houston Methodist Research Institute, Houston, Texas., Xiao L; Center for Translational Research in Hematological Malignancies, Houston Methodist Cancer Center/Houston Methodist Research Institute, Houston, Texas., Su P; Center for Translational Research in Hematological Malignancies, Houston Methodist Cancer Center/Houston Methodist Research Institute, Houston, Texas., Bi E; Center for Translational Research in Hematological Malignancies, Houston Methodist Cancer Center/Houston Methodist Research Institute, Houston, Texas., Huang YH; Center for Translational Research in Hematological Malignancies, Houston Methodist Cancer Center/Houston Methodist Research Institute, Houston, Texas., Qian J; Center for Translational Research in Hematological Malignancies, Houston Methodist Cancer Center/Houston Methodist Research Institute, Houston, Texas., Liu L; Center for Translational Research in Hematological Malignancies, Houston Methodist Cancer Center/Houston Methodist Research Institute, Houston, Texas., Ma X; Center for Translational Research in Hematological Malignancies, Houston Methodist Cancer Center/Houston Methodist Research Institute, Houston, Texas., Yang M; Center for Translational Research in Hematological Malignancies, Houston Methodist Cancer Center/Houston Methodist Research Institute, Houston, Texas., Xiong W; Center for Translational Research in Hematological Malignancies, Houston Methodist Cancer Center/Houston Methodist Research Institute, Houston, Texas., Zu Y; Department of Pathology and Genomic Medicine, Institute for Academic Medicine, Houston Methodist Research Institute, Houston, Texas; and., Pingali SR; Houston Methodist Cancer Center, Houston Methodist Hospital, Houston, Texas., Xu B; Department of Hematology, The First Affiliated Hospital of Xiamen University, Xiamen, Fujian, China., Yi Q; Center for Translational Research in Hematological Malignancies, Houston Methodist Cancer Center/Houston Methodist Research Institute, Houston, Texas.

المصدر: Blood [Blood] 2022 Jan 06; Vol. 139 (1), pp. 59-72.

نوع المنشور: Journal Article; Research Support, Non-U.S. Gov't

بيانات الدورية: Publisher: Elsevier Country of Publication: United States NLM ID: 7603509 Publication Model: Print Cited Medium: Internet ISSN: 1528-0020 (Electronic) Linking ISSN: 00064971 NLM ISO Abbreviation: Blood Subsets: MEDLINE

مواضيع طبية MeSH: Antineoplastic Agents/*pharmacology , Immunity, Innate/*drug effects , Multiple Myeloma/*drug therapy , Oligopeptides/*pharmacology , Receptors, Retinoic Acid/*agonists, 2',5'-Oligoadenylate Synthetase/immunology ; Cell Line, Tumor ; Endoribonucleases/immunology ; Humans ; Receptors, Retinoic Acid/immunology ; Tumor Cells, Cultured ; Retinoic Acid Receptor gamma